(NYSE: PRGO) Perrigo Co's forecast annual revenue growth rate of 0.57% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 8.99%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.06%.
Perrigo Co's revenue in 2026 is $4,178,400,000.On average, 6 Wall Street analysts forecast PRGO's revenue for 2026 to be $572,427,464,490, with the lowest PRGO revenue forecast at $544,892,278,260, and the highest PRGO revenue forecast at $591,937,320,060. On average, 6 Wall Street analysts forecast PRGO's revenue for 2027 to be $578,515,646,370, with the lowest PRGO revenue forecast at $548,628,208,050, and the highest PRGO revenue forecast at $600,792,857,340.
In 2028, PRGO is forecast to generate $589,031,596,890 in revenue, with the lowest revenue forecast at $553,055,976,690 and the highest revenue forecast at $613,937,795,490.